CalciMedica, Inc. (CALC) has a negative trailing P/E of -340.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -0.29%.
Criteria proven by this page:
Overall SharesGrow Score: 37/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2018 | -0.2 | 0.00 | 0.42 | 0.00 | - |
| 2019 | -0.2 | -0.02 | 0.21 | 0.00 | - |
| 2020 | -0.1 | 0.00 | 0.03 | 0.00 | - |
| 2021 | -0.2 | 0.00 | 0.14 | 0.00 | - |
| 2022 | -1.1 | 0.59 | -0.97 | 0.00 | - |
| 2023 | -0.4 | 0.01 | 1.57 | 0.00 | - |
| 2024 | -2.9 | 0.03 | 2.76 | 0.00 | - |
| 2025 | -3,346.3 | -54.43 | -14,896.04 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2018 | $-33.10 | $0.00 | $-28.38M | - |
| 2019 | $-35.85 | $0.00 | $-37.04M | - |
| 2020 | $-58.24 | $0.00 | $-27.53M | - |
| 2021 | $-23.66 | $0.00 | $-35.82M | - |
| 2022 | $-23.20 | $0.00 | $-35.61M | - |
| 2023 | $-7.65 | $0.00 | $-34.36M | - |
| 2024 | $-12.18 | $0.00 | $-13.7M | - |
| 2025 | $-1.97 | $0.00 | $-29.56M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-1.34 | $-1.61 – $-1.08 | $2.43M | $2.43M – $2.43M | 2 |
| 2027 | $-2.16 | $-3.48 – $-0.84 | $6.67M | $6.67M – $6.67M | 2 |
| 2028 | $-2.07 | $-3.54 – $-0.98 | $3.5M | $3.5M – $3.5M | 3 |
| 2029 | $-1.99 | $-1.99 – $-1.99 | $15.2M | $15.2M – $15.2M | 1 |
| 2030 | $-1.57 | $-1.57 – $-1.57 | $22.15M | $22.15M – $22.15M | 1 |
